Anti-C1q Antibody is Associated with Renal and Cutaneous Manifestations in Asian Indian Patients with Systemic Lupus Erythematosus

Journal Title: Journal of Clinical and Diagnostic Research - Year 2017, Vol 11, Issue 3

Abstract

Introduction: C1q play an important role in clearance of immune complexes and apoptotic cell debris. Impaired clearance leads to exposure of C1 native antigen and development of antiC1q antibody formation. Anti-C1q antibody is well studied in Systemic Lupus Erythematosus (SLE). Significance of anti-C1q Ab in Indian SLE patients and their clinical manifestations is not clear. Aim: The aim of this study was to investigate associations between anti-C1q antibody and clinical as well as serological markers of SLE. Materials and Methods: Retrospective study of SLE patients fulfilling either American College of Rheumatology (ACR) 1990 or Systemic Lupus International Collaborating Clinics (SLICC) 2012 classification criteria were recruited from inpatients and outpatients services of the Clinical immunology and Rheumatology Department, Christian Medical College at Vellore, India between March 2013 and January 2015. AntiC1q antibody was assayed by ELISA (Demeditec Diagnostics GmbH, Germany). Logistic regression analysis was performed to find the association of anti-C1q antibodies with serological and clinical parameters in SLE including Lupus Nephritis (LN). Results: Sixty nine patients (54.76%) out of 126 SLE patients had LN. Anti-C1q levels were higher in patients with LN as compared to those without (p<0.05). Anti-C1q antibody was also significantly associated with positive C1q immunofluorescence staining in renal biopsy specimens (p<0.05). Overall, renal Systemic Lupus Erythematosus Disease Activity Index (SLEDAI) {OR 1.35 (1.08-1.69)}, low C4 {OR 3.11 (1.04-9.26)} and mucocutaneous manifestation {OR 4.72 (1.38-16.05)} were independently associated with anti-C1q levels in serum. Conclusion: Renal SLEDAI, low C4 and mucocutaneous manifestations were independently associated with raised anti C1q antibody in SLE patients.

Authors and Affiliations

Jayakanthan Kabeerdos, Nikhil Gupta, Sandhya Pulukool, Hindhumathi Mohan, Gowri Mahasampath, Debashish Danda

Keywords

Related Articles

The Status of Knowledge Related to the Emergency Management of Avulsed Tooth amongst the Medical Practitioners of Nagpur, Central India

Introduction: Tooth avulsion is a frequently reported traumatic injury amongst young children and whenever it occurs, the parents or teachers of those children often seek the help of Medical Practitioners to provide the...

Assessment of Cytotoxicity of Titanium Tetrafluoride on Human Fibroblast Cell Line and Optimisation of Operational Conditions using Response Surface Methodology

Introduction: Fluoride products have an important effect on preventing Early Childhood Caries (ECC). Titanium tetrafluoride (TiF4)’s efficacy as a preventive agent suggests its use for inhibition of caries in man; howeve...

Carcinosarcoma Gallbladder: A Rare Variety of Gallbladder Malignancy

ABSTRACT Gallbladder malignancy is frequently found in Indian population. Most of them are adenocarcinoma variety whereas carcinosarcoma variety is quite rare. It is typically characterised by presence of both epithelial...

Benzodiazepine Induced Acute Pancreatitis

ABSTRACT Acute pancreatitis is acute inflammation of pancreas, caused mainly due to alcohol and gall stones. Drug induced pancreatitis is rare and benzodiazepine induced pancreatitis is still rare. Drug induced pancreati...

Download PDF file
  • EP ID EP335462
  • DOI 10.7860/JCDR/2017/22661.9545
  • Views 67
  • Downloads 0

How To Cite

Jayakanthan Kabeerdos, Nikhil Gupta, Sandhya Pulukool, Hindhumathi Mohan, Gowri Mahasampath, Debashish Danda (2017). Anti-C1q Antibody is Associated with Renal and Cutaneous Manifestations in Asian Indian Patients with Systemic Lupus Erythematosus. Journal of Clinical and Diagnostic Research, 11(3), 39-42. https://europub.co.uk/articles/-A-335462